Pfizer-BioNTech’s COVID-19 vaccine for children five to 11 is the subject of a meeting among U.S. FDA advisers on Tuesday. A recommendation on its potential use will be made.
U.S. FDA panel weighs authorization of Pfizer’s COVID-19 vaccine for kids
© The Crystal Eyes